Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.

Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision was updated to v3.6.6, indicating a new build of the site; it appears to be a behind-the-scenes update with no visible changes to the study details.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows a 503 error message with a 'Home' button and a footer revision note (Revision: v3.6.5), indicating the study record content is unavailable rather than updated. This aligns with an error page state rather than changes to the study data.SummaryDifference20%

- Check46 days agoChange DetectedThe page now displays revision v3.6.4, replacing the previous v3.6.3. This represents a minor template update rather than any content change.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision label was updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a minor update to the page version.SummaryDifference0.0%

- Check74 days agoChange Detected- The page footer shows Revision: v3.6.2, indicating an updated template/version is in use. The underlying study information and UI content remain the same, with no changes to study details or data.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page gains a recruitment status note stating no participants are being sought and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) with an updated revision label. It also standardizes the Intervention/Treatment label by removing the space around the slash.SummaryDifference0.4%

Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.